Articles > Popular publications > PR Newswire press releases > January-March 1998 > Thursday, March 26

Article: DuPont Merck Obtains U.S. Rights for Innohep(R) Anticoagulant Drug

Article from:
PR Newswire
Article date:
March 26, 1998
Copyright

WILMINGTON, Del., March 26 /PRNewswire/ -- DuPont Merck said today it has obtained U.S. rights for Innohep(R) (tinzaparin sodium) low-molecular weight heparin (LMWH) and expects to launch it in 1999 or 2000 for prevention and treatment of thrombosis.

"We expect that Innohep, if approved for marketing by the Food and Drug Administration, will be a valuable addition to our line of thrombosis products that are currently marketed or in clinical development," said Paul G. Howes, President and CEO of DuPont Merck.

A critical care medicine normally used in a hospital setting, Innohep(R) has completed clinical trials and is currently marketed in Canada ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: DuPont Pharmaceuticals Announces the Availability of ...
PR Newswire;  October 23, 2000 ;     700+ words ... ... Effectiveness, Safety and Convenience Earn Innohep(R) a Place in DuPont Pharmaceuticals ... once-daily low molecular weight heparin Innohep(R) (tinzaparin sodium injection ... Drug Administration (FDA) in July, Innohep is indicated for the treatment of acute ...

Article: Dupont Pharmaceuticals' Innohep(R) Receives FDA Approval ...
PR Newswire;  July 18, 2000 ;     700+ words ... ... low molecular weight heparin medication Innohep(R) (tinzaparin sodium injection ... sodium. The safety and effectiveness of Innohep(R) were established in hospitalized ... obtained the U.S. marketing rights for Innohep(R) from Leo Pharmaceutical Products ...

Article: Pharmion Launches First U.S. Product; New Sales Force Will Market ...
Business Wire;  October 3, 2002 ;     700+ words ... ... commercial product in the United States, Innohep(R) (tinzaparin sodium injection ... hematology and oncology communities. Innohep(R) is a once-daily low molecular ... number of units sold). Global sales of Innohep(R) were approximately $100 million ...

Article: DuPont Submits New Drug Application for innohep(R) for ...
PR Newswire;  July 1, 1999 ;     700+ words ... ... with the Food and Drug Administration for innohep(R) (tinzaparin sodium) injection ... trials in support of this NDA employed innohep(R) as a once-daily subcutaneous injection. "innohep(R) fits perfectly with our long-range ...

Article: Innohep: higher mortality rate than UFH in renally ...
Reactions Weekly;  January 10, 2009 ;     505 words ... ... added to the Adverse Reactions section of the label. * lnnohep in Renal Insufficiency Study Celgene Corporation. Important INNOHEP (Rm) (tinzaparin sodium injection) safety information. Internet Document : [2 pages], 31 Dec 2008. Available from ...

Article: Innohep.
Drug Utilization Review;  September 1, 2000 ;     273 words ...* Low-molecular-weight heparin Innohep (tinzaparin sodium) Injectable by Dupont Pharmaceutical Company for treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin sodium.

Article: DUPONT PHARMACEUTICALS Co.(Launched heparin prep ...
Chemical Market Reporter;  October 30, 2000 ;     482 words ...DUPONT PHARMACEUTICALS Co. launched its new once-daily low molecular weight heparin Innohep (tinzaparin sodium injection), which was approved by FDA in July, in the US market.

Article: Comtan climbs among newer antiparkinson drugs; Innohep ...
Formulary;  November 1, 2001 ;     514 words ... ... 2001, and there too Lovenox was on twice as many formularies (62%) as the next agent, Fragmin (30%). The new agent Innohep, approved in July 2000, had made it onto just 3.2% of hospital and 16% of managed care formularies in the most recent ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives